3,6′-Dithiothalidomide, a new TNF-α synthesis inhibitor, attenuates the effect of Aβ(1-42) intracerebroventricular injection on hippocampal neurogenesis and memory deficit

Lignende værker

• Tumor necrosis factor-α synthesis inhibitor 3,6′-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s disease
  af: Tweedie, David, et al.
  Udgivet: (2012)
• Cyclooxygenase-1 is involved in the inhibition of hippocampal neurogenesis after lipopolysaccharide-induced neuroinflammation
  af: Russo, Isabella, et al.
  Udgivet: (2011)
• 3,6′-Dithiothalidomide Improves Experimental Stroke Outcome by Suppressing Neuroinflammation
  af: Yoon, Jeong Seon, et al.
  Udgivet: (2013)
• Post-Injury Neuroprotective Effects of the Thalidomide Analog 3,6′-Dithiothalidomide on Traumatic Brain Injury
  af: Batsaikhan, Buyandelger, et al.
  Udgivet: (2019)
• Tumor necrosis factor-α synthesis inhibitor, 3’6,dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice
  af: Baratz, Renana, et al.
  Udgivet: (2011)